{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:36:02Z","timestamp":1789673762582,"version":"4.0.1"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00440","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T11:34:07Z","timestamp":1525088047000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":104,"title":["Targeting Renin\u2013Angiotensin System Against Alzheimer\u2019s Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Abadi Kahsu","family":"Gebre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birhanetensay Masresha","family":"Altaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfay Mehari","family":"Atey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kald Beshir","family":"Tuem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derbew Fikadu","family":"Berhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/917156","article-title":"Inhibition of ACE retards tau hyperphosphorylation and signs of neuronal degeneration in aged rats subjected to chronic mild stress.","volume":"2015","author":"AbdAlla","year":"2015","journal-title":"Biomed Res. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16917","DOI":"10.3390\/ijms140816917","article-title":"ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer\u2019s disease.","volume":"14","author":"AbdAlla","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1074\/jbc.M807746200","article-title":"Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease.","volume":"284","author":"AbdAlla","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nsmb.1799","article-title":"Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils.","volume":"17","author":"Ahmed","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00210-016-1234-6","article-title":"Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.","volume":"389","author":"Ali","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2174\/156720508785132307","article-title":"Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies.","volume":"5","author":"Alonso","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1749-6632.2000.tb06395.x","article-title":"The renin angiotensin system and Alzheimer\u2019s disease.","volume":"903","author":"Amouyel","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B8","first-page":"841","article-title":"The renin-angiotensin system and the neurodegenerative diseases: a brief review.","volume":"24","author":"Ana Flavia","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18553\/jmcp.2007.13.s8-b.9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.","author":"Atlas","year":"2007","journal-title":"J. Manag. Care Pharm."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7412.1000203","article-title":"Microtubule defects & neurodegeneration.","volume":"4","author":"Baird","year":"2013","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1567205012666141218140953","article-title":"Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease.","volume":"12","author":"Baranello","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1097\/00005344-199219006-00011","article-title":"Angiotensin-converting enzyme inhibition, angiotensin, and cognition.","author":"Barnes","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0006-8993(90)90294-L","article-title":"Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition.","volume":"507","author":"Barnes","year":"1990","journal-title":"Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2016.10.508","article-title":"HNE-modified proteins in down syndrome: Involvement in development of Alzheimer disease neuropathology.","volume":"111","author":"Barone","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"H1416","DOI":"10.1152\/ajpheart.00141.2007","article-title":"Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain.","volume":"293","author":"Becker","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood\u2013brain barrier disorder in Alzheimer\u2019s disease.","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10571-009-9368-4","article-title":"Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery.","volume":"29","author":"Benicky","year":"2009","journal-title":"Cell. Mol. Neurobiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1172\/JCI66541","article-title":"Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer\u2019s-like cognitive decline.","volume":"124","author":"Bernstein","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pnpbp.2012.12.009","article-title":"Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus.","volume":"43","author":"Bild","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/micc.12193","article-title":"Angiotensin and neurovascular coupling: beyond hypertension.","volume":"22","author":"Bloch","year":"2015","journal-title":"Microcirculation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis.","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/102602","article-title":"Renin angiotensin system in cognitive function and dementia.","volume":"2013","author":"Bodiga","year":"2013","journal-title":"Asian J. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4142\/jvs.2011.12.3.291","article-title":"Differential brain angiotensin-II type I receptor expression in hypertensive rats.","volume":"12","author":"Braga","year":"2011","journal-title":"J. Vet. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1523\/JNEUROSCI.5901-11.2012","article-title":"Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-beta1-42 oligomers are revealed in vivo by using a novel animal model.","volume":"32","author":"Brouillette","year":"2012","journal-title":"J. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(90)90063-F","article-title":"Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization.","volume":"114","author":"Bunnemann","year":"1990","journal-title":"Neurosci. Lett."},{"key":"B27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.31887\/DCNS.2003.5.1\/aburns","article-title":"Treatment of cognitive impairment in Alzheimer\u2019s disease.","volume":"5","author":"Burns","year":"2003","journal-title":"Dialogues Clin. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","article-title":"beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.","volume":"14","author":"Busciglio","year":"1995","journal-title":"Neuron"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/795375","article-title":"Amyloid beta: multiple mechanisms of toxicity and only some protective effects?","volume":"2014","author":"Carrillo-Mora","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0891-0618(00)00112-5","article-title":"Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography.","volume":"20","author":"Chai","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1089\/ars.2012.4585","article-title":"Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases.","volume":"19","author":"Chan","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"B32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1152\/japplphysiol.00455.2012","article-title":"Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain.","volume":"113","author":"Chrissobolis","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drudis.2010.11.016","article-title":"Angiotensin II receptors and drug discovery in cardiovascular disease.","volume":"16","author":"Dasgupta","year":"2011","journal-title":"Drug Discov. Today"},{"key":"B34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias.","volume":"26","author":"Davies","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/157180","article-title":"Brain RAS: hypertension and beyond.","volume":"2013","author":"de Gasparo","year":"2013","journal-title":"Int. J. Hypertens."},{"key":"B36","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.3233\/JAD-132189","article-title":"Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer\u2019s disease.","author":"de Oliveira","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2174\/1567205014666171016101816","article-title":"Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer\u2019s disease dementia.","volume":"15","author":"de Oliveira","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"B38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01320-6","article-title":"The blood-brain barrier in neuroinflammatory diseases.","volume":"49","author":"de Vries","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1096\/fj.11-182873","article-title":"Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer\u2019s disease.","volume":"25","author":"Dong","year":"2011","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"30471","DOI":"10.1074\/jbc.M605827200","article-title":"Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.","volume":"281","author":"Eckman","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1212\/01.WNL.0000106823.72493.FF","article-title":"Alzheimer disease risk and genetic variation in ACE: a meta-analysis.","volume":"62","author":"Elkins","year":"2004","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/jnnp.2006.104034","article-title":"The effects of commonly prescribed drugs in patients with Alzheimer\u2019s disease on the rate of deterioration.","volume":"78","author":"Ellul","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00004647-200404000-00012","article-title":"The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.","volume":"24","author":"Engelhorn","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/01616412.2015.1105626","article-title":"Telmisartan ameliorates oxidative stress and subarachnoid haemorrhage-induced cerebral vasospasm.","volume":"38","author":"Erdi","year":"2016","journal-title":"Neurol. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/jcbfm.2015.79","article-title":"Hypertension enhances Abeta-induced neurovascular dysfunction, promotes beta-secretase activity, and leads to amyloidogenic processing of APP.","volume":"36","author":"Faraco","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B46","first-page":"329","article-title":"Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors.","volume":"57","author":"Faure","year":"2006","journal-title":"J. Physiol. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5527\/wjn.v3.i3.64","article-title":"Renin-angiotensin system in the kidney: What is new?","volume":"3","author":"Ferr\u00e3o","year":"2014","journal-title":"World J. Nephrol."},{"key":"B48","first-page":"197","article-title":"Angiotensin II-inhibiting drugs have no effect on intraneuronal Abeta or oligomeric Abeta levels in a triple transgenic mouse model of Alzheimer\u2019s disease.","volume":"3","author":"Ferrington","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"B49","first-page":"151","article-title":"Angiotensin II-inhibition: effect on Alzheimer\u2019s pathology in the aged triple transgenic mouse.","volume":"4","author":"Ferrington","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00441-012-1354-3","article-title":"Immunohistochemical localization of the angiotensin-(1-7) receptor Mas in the murine forebrain.","volume":"348","author":"Freund","year":"2012","journal-title":"Cell Tissue Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/jcbfm.2014.221","article-title":"Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment.","volume":"35","author":"Fuchtemeier","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrneurol.2016.84","article-title":"Genetic variants in Alzheimer disease - molecular and brain network approaches.","volume":"12","author":"Gaiteri","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2011.00017","article-title":"Angiotensin II, a neuropeptide at the frontier between endocrinology and neuroscience: is there a link between the angiotensin ii type 2 receptor and Alzheimer\u2019s disease?","volume":"2","author":"Gallo-Payet","year":"2011","journal-title":"Front. Endocrinol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3109\/10641968309048844","article-title":"The tissue renin-angiotensin systems: focus on brain angiotensin, adrenal gland and arterial wall.","volume":"5","author":"Ganten","year":"1983","journal-title":"Clin. Exp. Hypertens. A"},{"key":"B55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1517\/14728222.8.1.7","article-title":"Angiotensin as a target for the treatment of Alzheimer\u2019s disease, anxiety and depression.","volume":"8","author":"Gard","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"B56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00429-012-0402-9","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin\u2013angiotensin system in the nigra.","volume":"218","author":"Garrido-Gil","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"B57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1021\/acschemneuro.5b00274","article-title":"Perindopril attenuates lipopolysaccharide-induced amyloidogenesis and memory impairment by suppression of oxidative stress and RAGE activation.","volume":"7","author":"Goel","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12035-017-0450-5","article-title":"Angiotensin II receptor blockers attenuate lipopolysaccharide-induced memory impairment by modulation of NF-kappaB-Mediated BDNF\/CREB expression and apoptosis in spontaneously hypertensive rats.","volume":"55","author":"Goel","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","article-title":"beta-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease.","volume":"12","author":"Gouras","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neures.2004.07.010","article-title":"Angiotensin type 2 receptor neuroprotection against chemical hypoxia is dependent on the delayed rectifier K+ channel, Na+\/Ca2+ exchanger and Na+\/K+ ATPase in primary cortical cultures.","volume":"50","author":"Grammatopoulos","year":"2004","journal-title":"Neurosci. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cmet.2010.09.011","article-title":"The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance.","volume":"12","author":"Grobe","year":"2010","journal-title":"Cell Metab."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/351758","article-title":"The angiotensin II type 2 receptor in brain functions: an update.","volume":"2012","author":"Guimond","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"B63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1447-0594.2009.00571.x","article-title":"Lipids\u2019 peroxidation markers in Alzheimer\u2019s disease and vascular dementia.","volume":"10","author":"Gustaw-Rothenberg","year":"2010","journal-title":"Geriatr. Gerontol. Int."},{"key":"B64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1533317507309803","article-title":"Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer\u2019s disease: an observational study.","volume":"23","author":"Hajjar","year":"2008","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"B65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/pds.3449","article-title":"Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors.","volume":"22","author":"Hebert","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neulet.2009.06.006","article-title":"An age effect on the association of common variants of ACE with Alzheimer\u2019s disease.","volume":"461","author":"Helbecque","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B68","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mcn.2005.03.012","article-title":"Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas.","volume":"29","author":"Hellner","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.","volume":"280","author":"Hemming","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2007.01.004","article-title":"Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.","volume":"26","author":"Hemming","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1007\/s00259-007-0699-4","article-title":"Acetylcholine esterase activity in mild cognitive impairment and Alzheimer\u2019s disease.","author":"Herholz","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbapap.2005.02.013","article-title":"Understanding molecular mechanisms of proteolysis in Alzheimer\u2019s disease: progress toward therapeutic interventions.","volume":"1751","author":"Higuchi","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B73","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1600-0773.1995.tb01032.x","article-title":"Angiotensin receptors in the brain.","volume":"77","author":"Hohle","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1600-0404.2009.01299.x","article-title":"Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial.","volume":"121","author":"Hong","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1470320309347793","article-title":"The angiotensin II type 2 receptor in the brain.","volume":"11","author":"Horiuchi","year":"2010","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"B76","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/00029330-200811020-00019","article-title":"Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease.","volume":"121","author":"Hou","year":"2008","journal-title":"Chin. Med. J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-receptor blockers and risk of Alzheimer\u2019s disease in hypertension population\u2013a nationwide cohort study.","volume":"77","author":"Hsu","year":"2013","journal-title":"Circ. J."},{"key":"B78","doi-asserted-by":"publisher","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.","volume":"276","author":"Hu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2.","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yexcr.2004.09.032","article-title":"Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.","volume":"304","author":"Inestrosa","year":"2005","journal-title":"Exp. Cell Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Mechanisms of tau-induced neurodegeneration.","volume":"118","author":"Iqbal","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1161\/01.STR.0000027274.03779.F3","article-title":"Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.","volume":"33","author":"Ito","year":"2002","journal-title":"Stroke"},{"key":"B83","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/HJH.0b013e32833a551a","article-title":"Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.","volume":"28","author":"Iwanami","year":"2010","journal-title":"J. Hypertens."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: the renin angiotensin system.","volume":"19","author":"Jackson","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/jcbfm.2011.133","article-title":"Direct stimulation of angiotensin II type 2 receptor enhances spatial memory.","volume":"32","author":"Jing","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1097\/00001756-199512150-00024","article-title":"AT1A, AT1B, and AT2 angiotensin II receptor subtype gene expression in rat brain.","volume":"6","author":"Johren","year":"1995","journal-title":"Neuroreport"},{"key":"B88","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/0006-291X(92)91680-O","article-title":"Differential expression of angiotensin II receptor subtype mRNAs (AT-1A and AT-1B) in the brain.","volume":"185","author":"Kakar","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics.","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"B90","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/01.WNL.0000151958.79884.86","article-title":"Independent accumulations of tau and amyloid \u03b2-protein in the human entorhinal cortex.","volume":"64","author":"Katsuno","year":"2005","journal-title":"Neurology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt3","article-title":"Angiotensins and Alzheimer\u2019s disease: a bench to bedside overview.","volume":"1","author":"Kehoe","year":"2009","journal-title":"Alzheimers Res. Ther."},{"key":"B92","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","article-title":"Abeta40 inhibits amyloid deposition in vivo.","volume":"27","author":"Kim","year":"2007","journal-title":"J. Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neulet.2004.11.062","article-title":"ACE I\/D polymorphism is a risk factor of Alzheimer\u2019s disease but not of vascular dementia.","volume":"377","author":"Kolsch","year":"2005","journal-title":"Neurosci. Lett."},{"key":"B94","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1447-0594.2011.00746.x","article-title":"Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer\u2019s disease.","volume":"12","author":"Kume","year":"2012","journal-title":"Geriatr. Gerontol. Int."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1172\/JCI41709","article-title":"Angiotensin II sustains brain inflammation in mice via TGF-beta.","volume":"120","author":"Lanz","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B96","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nlm.2011.10.003","article-title":"Angiotensin-(1-7)\/Mas axis integrity is required for the expression of object recognition memory.","volume":"97","author":"Lazaroni","year":"2012","journal-title":"Neurobiol. Learn. Mem."},{"key":"B97","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1096-9861(19960923)373:3<322::AID-CNE2>3.0.CO;2-4","article-title":"Distribution of angiotensin II type-2 receptor (AT2) mRNA expression in the adult rat brain.","volume":"373","author":"Lenkei","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1006\/frne.1997.0155","article-title":"Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review.","volume":"18","author":"Lenkei","year":"1997","journal-title":"Front. Neuroendocrinol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1096\/fj.04-2960fje","article-title":"Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"B101","first-page":"2743","article-title":"[Effects of telmisartan on the level of Abeta1-42, interleukin-1beta, tumor necrosis factor alpha and cognition in hypertensive patients with Alzheimer\u2019s disease].","volume":"92","author":"Li","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/jnr.23404","article-title":"Conversion of Abeta43 to Abeta40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.","volume":"92","author":"Liu","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ntt.2014.11.004","article-title":"Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson\u2019s disease in CATH.a cells.","volume":"47","author":"Lu","year":"2015","journal-title":"Neurotoxicol. Teratol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(95)00076-3","article-title":"Angiotensin II receptor subtypes in the human central nervous system.","volume":"675","author":"MacGregor","year":"1995","journal-title":"Brain Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the renin\u2013angiotensin system in vascular inflammation.","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/hr.2009.143","article-title":"Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke.","volume":"32","author":"Matsumoto","year":"2009","journal-title":"Hypertens. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/00207450903389362","article-title":"The angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke.","volume":"120","author":"Matsumoto","year":"2010","journal-title":"Int. J. Neurosci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1161\/01.HYP.0000173421.97463.ac","article-title":"Electrophysiological properties of rostral ventrolateral medulla neurons in angiotensin II 1a receptor knockout mice.","volume":"46","author":"Matsuura","year":"2005","journal-title":"Hypertension"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1161\/STROKEAHA.108.531509","article-title":"Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke.","volume":"40","author":"McCarthy","year":"2009","journal-title":"Stroke"},{"key":"B110","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1357-2725(02)00306-0","article-title":"The brain renin-angiotensin system: location and physiological roles.","volume":"35","author":"McKinley","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"11440","DOI":"10.1073\/pnas.88.24.11440","article-title":"Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development.","volume":"88","author":"Millan","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/169649","article-title":"Roles of brain angiotensin II in cognitive function and dementia.","volume":"2012","author":"Mogi","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"B113","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bbrc.2008.08.032","article-title":"Telmisartan prevented cognitive decline partly due to PPAR-gamma activation.","volume":"375","author":"Mogi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B114","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/sj.jhh.1001735","article-title":"Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke.","volume":"18","author":"Moriwaki","year":"2004","journal-title":"J. Hum. Hypertens."},{"key":"B115","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the \u03b2-Amyloid peptide.","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1021\/ja8092604","article-title":"Amyloid \u03b2-protein: A\u03b240 Inhibits A\u03b242 Oligomerization.","volume":"131","author":"Murray","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"B117","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ajh\/hpw099","article-title":"Transient mild cerebral ischemia significantly deteriorated cognitive impairment in a mouse model of Alzheimer\u2019s disease via angiotensin AT1 receptor.","volume":"30","author":"Nakagawa","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"B118","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2012.11.008","article-title":"AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression.","volume":"51","author":"Namsolleck","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/hc0302.102618","article-title":"The AT1-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.","volume":"105","author":"Nickenig","year":"2002","journal-title":"Circulation"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1097\/HJH.0b013e32830dd5d3","article-title":"Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla.","volume":"26","author":"Nozoe","year":"2008","journal-title":"J. Hypertens."},{"key":"B121","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1460-9568.2005.03912.x","article-title":"The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.","volume":"21","author":"Oba","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"B122","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3233\/JAD-131694","article-title":"Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer\u2019s disease.","volume":"40","author":"O\u2019Caoimh","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","article-title":"Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer\u2019s disease model.","volume":"68","author":"Ongali","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B124","first-page":"232","article-title":"Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia\/reperfusion injury in rats.","volume":"18","author":"Panahpour","year":"2014","journal-title":"Iran. Biomed. J."},{"key":"B125","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems.","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/175428","article-title":"Immunohistochemical localization of, and angiotensin II receptor subtypes in the rat adrenal, pituitary, and brain with a perspective commentary.","volume":"2013","author":"Premer","year":"2013","journal-title":"Int. J. Hypertens."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/191863","article-title":"The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer\u2019s disease.","volume":"2014","author":"Provias","year":"2014","journal-title":"Int. J. Alzheimers Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/1389557516666161025094539","article-title":"Angiotensin mediated oxidative stress and neuroprotective potential of antioxidants and AT1 receptor blockers.","volume":"17","author":"Prusty","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"B129","doi-asserted-by":"publisher","first-page":"E763","DOI":"10.1152\/ajpendo.1992.262.6.E763","article-title":"Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure.","volume":"262","author":"Reid","year":"1992","journal-title":"Am. J. Physiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.109.147843","article-title":"Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.","volume":"55","author":"Rompe","year":"2010","journal-title":"Hypertension"},{"key":"B131","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1523\/JNEUROSCI.0329-17.2017","article-title":"Angiotensin IV receptors mediate the cognitive and cerebrovascular benefits of losartan in a mouse model of Alzheimer\u2019s disease.","volume":"37","author":"Royea","year":"2017","journal-title":"J. Neurosci."},{"key":"B132","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.29.1_supplement.968.19","article-title":"Angiotensin II reduces mRNA expression for glutamate transporters and glutamine synthetase in cultured hypothalamic astrocytes.","volume":"29","author":"Ruginsk","year":"2015","journal-title":"FASEB J."},{"key":"B133","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/CS20120078","article-title":"Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.","volume":"123","author":"Saavedra","year":"2012","journal-title":"Clin. Sci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10571-015-0327-y","article-title":"Evidence to consider angiotensin II receptor blockers for the treatment of early Alzheimer\u2019s disease.","volume":"36","author":"Saavedra","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.regpep.2004.12.015","article-title":"Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists.","volume":"128","author":"Saavedra","year":"2005","journal-title":"Regul. Pept."},{"key":"B136","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/156720207782446351","article-title":"Advanced glycation end products, oxidative stress and metalloproteinases are altered in the cerebral microvasculature during aging.","volume":"4","author":"Safciuc","year":"2007","journal-title":"Curr. Neurovasc. Res."},{"key":"B137","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3233\/JAD-132483","article-title":"The emerging role of glutathione in Alzheimer\u2019s disease.","volume":"40","author":"Saharan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1139\/cjpp-2014-0108","article-title":"Enhancement of renal oxidative stress by injection of angiotensin II into the paraventricular nucleus in renal ischemia-reperfusion injury.","volume":"92","author":"Seifi","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jss.2014.06.042","article-title":"Angiotensin II in paraventricular nucleus contributes to sympathoexcitation in renal ischemia-reperfusion injury by AT1 receptor and oxidative stress.","volume":"193","author":"Seifi","year":"2015","journal-title":"J. Surg. Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"8187","DOI":"10.1523\/JNEUROSCI.17-21-08187.1997","article-title":"Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain.","volume":"17","author":"Shin","year":"1997","journal-title":"J. Neurosci."},{"key":"B141","article-title":"Angiotensin receptors: structure, function, signaling and clinical applications.","volume":"1","author":"Singh","year":"2016","journal-title":"J. Cell Signal."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the cardiovascular health study.","volume":"169","author":"Sink","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10571-014-0152-8","article-title":"Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.","volume":"35","author":"So","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1440-1681.1991.tb01414.x","article-title":"Angiotensin II receptor subtypes in rat brain.","volume":"18","author":"Song","year":"1991","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/cne.903160407","article-title":"Mapping of angiotensin II receptor subtype heterogeneity in rat brain.","volume":"316","author":"Song","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/jgs.12415","article-title":"Angiotensin-converting enzyme inhibitors and Alzheimer\u2019s disease progression in older adults: results from the Reseau sur la Maladie d\u2019Alzheimer Francais cohort.","volume":"61","author":"Soto","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cphy.c130040","article-title":"Classical renin-angiotensin system in kidney physiology.","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr. Physiol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejphar.2008.03.058","article-title":"Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.","volume":"588","author":"Sun","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ceca.2009.12.014","article-title":"The dysregulation of intracellular calcium in Alzheimer disease.","volume":"47","author":"Supnet","year":"2010","journal-title":"Cell Calcium"},{"key":"B150","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1291\/hypres.29.621","article-title":"Valsartan improves the lower limit of cerebral autoregulation in rats.","volume":"29","author":"Takada","year":"2006","journal-title":"Hypertens. Res."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004897","article-title":"Detrimental effects of centrally administered angiotensin II are enhanced in a mouse model of Alzheimer disease independently of blood pressure.","volume":"6","author":"Takane","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B152","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/ajh\/hpw158","article-title":"Angiotensin receptor blocker protects Alzheimer\u2019s disease brain from ischemic insult.","volume":"30","author":"Takeda","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.109.138586","article-title":"Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling.","volume":"54","author":"Takeda","year":"2009","journal-title":"Hypertension"},{"key":"B154","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1016\/j.febslet.2012.09.004","article-title":"Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains.","volume":"586","author":"Tian","year":"2012","journal-title":"FEBS Lett."},{"key":"B155","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00213-012-2913-8","article-title":"Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats.","volume":"226","author":"Tota","year":"2013","journal-title":"Psychopharmacology"},{"key":"B156","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbr.2008.11.044","article-title":"Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin.","volume":"199","author":"Tota","year":"2009","journal-title":"Behav. Brain Res."},{"key":"B157","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bbr.2011.07.047","article-title":"Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats.","volume":"226","author":"Tota","year":"2012","journal-title":"Behav. Brain Res."},{"key":"B158","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1152\/ajpregu.1991.261.1.R209","article-title":"Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain.","volume":"261","author":"Tsutsumi","year":"1991","journal-title":"Am. J. Physiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JAD-150642","article-title":"Intracerebroventricular infusion of angiotensin-(1-7) ameliorates cognitive impairment and memory dysfunction in a mouse model of Alzheimer\u2019s disease.","volume":"53","author":"Uekawa","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B160","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s13311-014-0286-x","article-title":"Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.","volume":"11","author":"Umschweif","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.327","article-title":"Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Cell Death Dis."},{"key":"B162","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2012.03.021","article-title":"Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats.","volume":"1453","author":"Vargas","year":"2012","journal-title":"Brain Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/002215549804600303","article-title":"Angiotensinogen, prorenin, and renin are Co-localized in the secretory granules of all glandular cells of the rat anterior pituitary: an immunoultrastructural study.","volume":"46","author":"Vila-Porcile","year":"1998","journal-title":"J. Histochem. Cytochem."},{"key":"B164","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2011.06.014","article-title":"Angiotensin II does not directly affect Abeta secretion or beta-\/gamma-secretase activity via activation of angiotensin II type 1 receptor.","volume":"500","author":"Wang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B166","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1006\/bbrc.1996.1895","article-title":"Expression of angiotensinogen mRNA and localization of angiotensin II and renin in peripheral adrenergic neurons in primary culture.","volume":"229","author":"Wang","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B167","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1471-4159.2009.06170.x","article-title":"Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.","volume":"110","author":"Welander","year":"2009","journal-title":"J. Neurochem."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/jgs.13627","article-title":"Renin-angiotensin-system modulation may slow the conversion from mild cognitive impairment to Alzheimer\u2019s disease.","volume":"63","author":"Wharton","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"key":"B169","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2012-120763","article-title":"The effects of ramipril in individuals at risk for Alzheimer\u2019s disease: results of a pilot clinical trial.","volume":"32","author":"Wharton","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.pharep.2013.11.002","article-title":"Telmisartan attenuates cognitive impairment caused by chronic stress in rats.","volume":"66","author":"Wincewicz","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.6064\/2012\/796024","article-title":"The role of tau in neurodegenerative diseases and its potential as a therapeutic target.","volume":"2012","author":"Wolfe","year":"2012","journal-title":"Scientifica"},{"key":"B172","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1523\/JNEUROSCI.19-10-03952.1999","article-title":"Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning.","volume":"19","author":"Wright","year":"1999","journal-title":"J. Neurosci."},{"key":"B173","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","article-title":"Mechanisms of neuronal degeneration in Alzheimer\u2019s disease.","volume":"16","author":"Yankner","year":"1996","journal-title":"Neuron"},{"key":"B174","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5049\/EBP.2008.6.1.42","article-title":"Renin-angiotensin system - Considerations for hypertension and kidney.","volume":"6","author":"Yim","year":"2008","journal-title":"Electrolyte Blood Press."},{"key":"B175","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0306-4522(02)00404-9","article-title":"Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.","volume":"115","author":"Zheng","year":"2002","journal-title":"Neuroscience"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016037","article-title":"Central angiotensin II stimulation promotes beta amyloid production in sprague dawley rats.","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"B177","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jocn.2016.02.036","article-title":"The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer\u2019s disease: a meta-analysis.","volume":"33","author":"Zhuang","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1097\/00004872-199816121-00026","article-title":"Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.","volume":"16","author":"Zhuo","year":"1998","journal-title":"J. Hypertens."},{"key":"B179","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders.","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"B180","doi-asserted-by":"publisher","first-page":"31914","DOI":"10.1074\/jbc.M109.011437","article-title":"A\u03b242-to-A\u03b240- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.","volume":"284","author":"Zou","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B181","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1523\/JNEUROSCI.1549-07.2007","article-title":"Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.","volume":"27","author":"Zou","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:49:29Z","timestamp":1751590169000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":181,"alternative-id":["10.3389\/fphar.2018.00440"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00440","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]},"article-number":"440"}}